Since 2016, Royal Philips has conducted original research to help determine the readiness of countries to address global health challenges and build efficient and effective health systems. In the context of ever-growing pressure on resources and costs, the Future Health Index focuses on the crucial role digital tools and connected care technology can play in delivering more affordable, integrated and sustainable healthcare.
In 2016, the Future Health Index measured perceptions of healthcare to produce a snapshot of how healthcare is experienced on both sides of the patient-professional divide. In 2017, it compared these perceptions to the reality of health systems in each country researched. In 2018, the Future Health Index identified key challenges to the large-scale adoption of value-based healthcare and overall improved access. It assessed where connected care technology can help speed up the healthcare transformation process. In 2019, the Future Health Index explored technology’s impact on two aspects of the Quadruple Aim: the healthcare experience for both patients and healthcare professionals1 and how technology is moving us to a new era of continuous transformation. In 2020, the Future Health Index examined the expectations and experiences of younger healthcare professionals aged under 40 and how they can be empowered to meet the demands of tomorrow’s healthcare. Last year, the Future Health Index 2021 considered how healthcare leaders* were meeting the continuing demands of the pandemic and what the new reality of healthcare post-crisis might look like.
In 2022, the Future Health Index concentrates on how healthcare leaders are now refocusing on the priorities and initiatives which were paused during the pandemic. They are increasingly incorporating data, advanced analytics tools and artificial intelligence to mitigate operational and clinical challenges and to enhance their ability to deliver care to communities both in and out of traditional hospital settings.
The research for the 2022 Future Health Index was conducted in 15 countries (Australia, Brazil, China**, France, Germany, India, Indonesia, Italy, the Netherlands, Poland, Russia, Saudi Arabia, Singapore, South Africa and the United States).
To provide a holistic understanding of the current healthcare systems around the world, the 2022 study combines a quantitative survey and qualitative interviews conducted from December 2021 – March 2022.
* Healthcare leader is defined as a C-suite or senior executive working in a hospital, medical practice, imaging center/office-based lab, or urgent care facility who is a final decision maker or has influence in making decisions.
**Survey data is representative of Mainland China only and does not include Taiwan or Hong Kong.